Tuesday, December 2, 2014

12/2/2014 Market Wrap

News:
FNJN announced they will be presenting at three upcoming
investor conferences.
NTIP announced the issuance of two new patents.
TIVO announced they will be presenting at two upcoming
investor conferences.
TSRA announced they have closed the O-film transaction and
increased Q4 revenue guidance.
Filings:
PTNT 8K
SITO 10K
Trading Commentary:
Ticker $CHG %CHG  Volume      Closing 
Price
ACTG  $         0.49 2.66%         418,100  $18.97
BCYP.OB  unch  unch         147,200  $0.08
CLGL (MVPI) -0.0051 -1.70%            40,400  $0.2949
COPY (ITUS) unch unch              6,600  $0.15
CRDS  $         0.01 0.37%            13,000  $2.70
DSS     $  (0.0300) -5.88%            89,600  $0.48
EDIG.OB  $  (0.0005) -1.22%         177,200  $0.0405
ENIP  unch  unch              5,900  $0.0202
INVT (EONC)  $    0.0399 5.18%            88,900  $0.8099
FNJN  $      (0.01) -0.42%              6,700  $2.37
IDCC  $         0.78 1.54%         664,800  $51.12
MARA  $         0.35 2.40%            17,300  $14.95
MGT  $    0.0084 1.12%            25,900  $0.76
NTIP  $         0.05 2.37%              4,400  $2.16
OTIV  $         0.05 3.07%         474,100  $1.68
PCO   unch  unch         149,900  $1.39
PPRO  $         0.02 0.78%              4,400  $2.60
PRKR  $    (0.096) -9.71%      1,506,000  $0.893
PTNT  $      (0.06) -2.08%              7,300  $2.83
RMBS  $         0.26 2.29%         336,500  $11.67
SITO.OB  $    (0.015) -5.56%            50,500  $0.255
SPEX   $         0.01 0.90%         258,000  $1.12
STRP  $         0.34 1.71%         149,700  $20.20
TIVO  $         0.02 0.18%      2,391,400  $12.07
TSRA  $         0.17 0.51%      1,053,400  $34.58
UPIP  $         0.02 1.51%         275,600  $1.36
VHC   $      (0.05) -1.03%         386,000  $4.81
VRNG  $    0.0057 0.63%         810,400  $0.9057
WDDD.OB  $    (0.005) -3.33%            74,700  $0.145
WILN   $      (0.01) -0.32%            20,700  $3.14

1 comment:

  1. Glenmark Pharmaceuticals Inc., USA has received final approval by the USFDA for HAILEYTM Fe 1/20, the generic version of Loestrin Fe 1/20 Tablets, of Allergan Pharmaceuticals International Limited.
    Stock Advisory Company

    ReplyDelete